Total submissions: 5
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV000677027 | SCV000251315 | uncertain significance | not provided | 2025-02-20 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
| Eurofins Ntd Llc |
RCV000677027 | SCV000861311 | uncertain significance | not provided | 2018-05-11 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV000677027 | SCV002260390 | uncertain significance | not provided | 2022-05-04 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with arginine, which is basic and polar, at codon 59 of the DGUOK protein (p.Thr59Arg). This variant is present in population databases (rs144907403, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with DGUOK-related conditions. ClinVar contains an entry for this variant (Variation ID: 214277). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
| Revvity Omics, |
RCV000677027 | SCV003829071 | uncertain significance | not provided | 2022-04-21 | criteria provided, single submitter | clinical testing | |
| Mayo Clinic Laboratories, |
RCV000677027 | SCV000802861 | uncertain significance | not provided | 2016-03-14 | no assertion criteria provided | clinical testing |